Carcinosin (Deseret Biologicals, Inc.)
Welcome to the PulseAid listing for the Carcinosin drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Deseret Biologicals, Inc. |
| NON-PROPRIETARY NAME: | Carcinosin |
| SUBSTANCE NAME: | HUMAN BREAST TUMOR CELL |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2012-10-08 |
| END MARKETING DATE: | 2020-09-02 |
Carcinosin HUMAN OTC DRUG Details:
| Item Description | Carcinosin from Deseret Biologicals, Inc. |
| LABELER NAME: | Deseret Biologicals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30([hp_C]/mL) |
| START MARKETING DATE: | 2012-10-08 |
| END MARKETING DATE: | 2020-09-02 |
| PRODUCT ID: | 43742-0208_d6814660-ae4e-4885-99bb-b929a93b7a5e |
| PRODUCT NDC: | 43742-0208 |
| APPLICATION NUMBER: | |
Other HUMAN BREAST TUMOR CELL Pharmaceutical Manufacturers / Labelers:
